From: Mortality in Western Australian seniors with chronic respiratory diseases: a cohort study
Patient Characteristic | All patients | SABs | Low dose ICS | Medium dose ICS ± LABs | High dose ICS ± LABs ± OS | P-value for interaction |
---|---|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | ||
Gender* | ||||||
Female | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Male | 1.72 (1.65-1.80) | 1.53 (1.40-1.67) | 1.56 (1.35-1.82) | 1.64 (1.50-1.79) | 1.97 (1.84-2.10) | 0.0003 |
Race* | ||||||
Non-Indigenous | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Indigenous | 1.28 (0.94-1.73) | 1.38 (0.79-2.42) | 1.06 (0.25-4.58) | 1.36 (0.70-2.65) | 1.18 (0.74-1.87) | 0.8841 |
Socioeconomic status quintile* | ||||||
Least disadvantaged | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
2nd least disadvantaged | 1.03 (0.96-1.10) | 1.03 (0.90-1.17) | 1.03 (0.81-1.31) | 0.99 (0.87-1.14) | 1.04 (0.93-1.15) | 0.8144 |
Medium disadvantaged | 1.05 (0.98-1.12) | 0.99 (0.86-1.13) | 1.03 (0.82-1.31) | 1.05 (0.91-1.20) | 1.07 (0.96-1.19) | 0.5340 |
2nd most disadvantaged | 1.06 (0.99-1.14) | 0.97 (0.85-1.12) | 1.20 (0.96-1.51) | 1.06 (0.93-1.22) | 1.07 (0.96-1.19) | 0.7491 |
Most disadvantaged | 1.16 (1.08-1.24) | 1.00 (0.87-1.15) | 1.14 (0.91-1.44) | 1.25 (1.09-1.42) | 1.19 (1.07-1.31) | 0.1161 |
Residential remoteness* | ||||||
Major Cities | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Inner Regional | 0.95 (0.89-1.01) | 1.00 (0.88-1.15) | 1.04 (0.83-1.32) | 0.99 (0.87-1.13) | 0.87 (0.79-0.97) | 0.2424 |
Outer Regional | 1.00 (0.92-1.07) | 1.06 (0.91-1.23) | 1.00 (0.76-1.32) | 0.97 (0.84-1.13) | 0.97 (0.87-1.09) | 0.5563 |
Remote | 0.83 (0.70-0.99) | 0.88 (0.61-1.26) | 0.58 (0.24-1.41) | 1.09 (0.81-1.45) | 0.70 (0.54-0.90) | 0.4457 |
Very Remote | 0.87 (0.58-1.30) | 0.49 (0.18-1.36) | 0.62 (0.08-4.79) | 1.13 (0.56-2.28) | 1.01 (0.56-1.84) | 0.1967 |